Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

Expression of adrenomedullin in human colorectal tumors and its role in cell growth and invasion in vitro and in xenograft growth in vivo.

Nouguerède E, Berenguer C, Garcia S, Bennani B, Delfino C, Nanni I, Dahan L, Gasmi M, Seitz JF, Martin PM, Ouafik L.

Cancer Med. 2013 Apr;2(2):196-207. doi: 10.1002/cam4.51.

2.

Adrenomedullin blockade suppresses growth of human hormone-independent prostate tumor xenograft in mice.

Berenguer-Daizé C, Boudouresque F, Bastide C, Tounsi A, Benyahia Z, Acunzo J, Dussault N, Delfino C, Baeza N, Daniel L, Cayol M, Rossi D, El Battari A, Bertin D, Mabrouk K, Martin PM, Ouafik L.

Clin Cancer Res. 2013 Nov 15;19(22):6138-50. doi: 10.1158/1078-0432.CCR-13-0691.

3.

Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.

Greillier L, Tounsi A, Berenguer-Daizé C, Dussault N, Delfino C, Benyahia Z, Cayol M, Mabrouk K, Garcia S, Martin PM, Barlesi F, Ouafik L.

J Thorac Oncol. 2016 Jan;11(1):94-107. doi: 10.1016/j.jtho.2015.09.004.

4.

Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma.

Deville JL, Bartoli C, Berenguer C, Fernandez-Sauze S, Kaafarani I, Delfino C, Fina F, Salas S, Muracciole X, Mancini J, Lechevallier E, Martin PM, Figarella-Branger D, Ouafik L, Daniel L.

Int J Cancer. 2009 Nov 15;125(10):2307-15. doi: 10.1002/ijc.24568.

5.

Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth of human tumor xenografts in mice.

Kaafarani I, Fernandez-Sauze S, Berenguer C, Chinot O, Delfino C, Dussert C, Metellus P, Boudouresque F, Mabrouk K, Grisoli F, Figarella-Branger D, Martin PM, Ouafik L.

FASEB J. 2009 Oct;23(10):3424-35. doi: 10.1096/fj.08-127852.

PMID:
19546305
6.

Shared and separate functions of the RAMP-based adrenomedullin receptors.

Kuwasako K, Kitamura K, Nagata S, Hikosaka T, Takei Y, Kato J.

Peptides. 2011 Jul;32(7):1540-50. doi: 10.1016/j.peptides.2011.05.022. Review.

PMID:
21645567
7.

Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.

Watkins HA, Walker CS, Ly KN, Bailey RJ, Barwell J, Poyner DR, Hay DL.

Br J Pharmacol. 2014 Feb;171(3):772-88. doi: 10.1111/bph.12508.

8.

Expression and distribution of the adrenomedullin system in newborn human thymus.

De Martin S, Paliuri G, Belloni A, Orso G, Zanarella E, Stellin G, Milanesi O, Basso G, Ruga EM, Frasson C, Gabbia D, Perdoncin G, Palatini P, Bova S.

PLoS One. 2014 May 15;9(5):e97592. doi: 10.1371/journal.pone.0097592.

9.

Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors.

Fernandez-Sauze S, Delfino C, Mabrouk K, Dussert C, Chinot O, Martin PM, Grisoli F, Ouafik L, Boudouresque F.

Int J Cancer. 2004 Mar 1;108(6):797-804.

10.

Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular Properties.

Watkins HA, Chakravarthy M, Abhayawardana RS, Gingell JJ, Garelja M, Pardamwar M, McElhinney JM, Lathbridge A, Constantine A, Harris PW, Yuen TY, Brimble MA, Barwell J, Poyner DR, Woolley MJ, Conner AC, Pioszak AA, Reynolds CA, Hay DL.

J Biol Chem. 2016 May 27;291(22):11657-75. doi: 10.1074/jbc.M115.688218.

11.

Adrenomedullin production is increased in colorectal adenocarcinomas; its relation to matrix metalloproteinase-9.

Hikosaka T, Tsuruda T, Nagata S, Kuwasako K, Tsuchiya K, Hoshiko S, Inatsu H, Chijiiwa K, Kitamura K.

Peptides. 2011 Sep;32(9):1825-31. doi: 10.1016/j.peptides.2011.07.012.

PMID:
21839130
12.
13.

Stromal fibroblasts present in breast carcinomas promote tumor growth and angiogenesis through adrenomedullin secretion.

Benyahia Z, Dussault N, Cayol M, Sigaud R, Berenguer-Daizé C, Delfino C, Tounsi A, Garcia S, Martin PM, Mabrouk K, Ouafik L.

Oncotarget. 2017 Feb 2. doi: 10.18632/oncotarget.14999. [Epub ahead of print]

14.

Temporo-spatial expression of adrenomedullin and its receptors in the bovine placenta.

Hayashi KG, Hosoe M, Sakumoto R, Takahashi T.

Reprod Biol Endocrinol. 2013 Jul 13;11:62. doi: 10.1186/1477-7827-11-62.

15.

Characterization of the single transmembrane domain of human receptor activity-modifying protein 3 in adrenomedullin receptor internalization.

Kuwasako K, Kitamura K, Nagata S, Nozaki N, Kato J.

Biochem Biophys Res Commun. 2012 Apr 13;420(3):582-7. doi: 10.1016/j.bbrc.2012.03.037.

PMID:
22445753
16.

Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo.

Ouafik L, Sauze S, Boudouresque F, Chinot O, Delfino C, Fina F, Vuaroqueaux V, Dussert C, Palmari J, Dufour H, Grisoli F, Casellas P, Brünner N, Martin PM.

Am J Pathol. 2002 Apr;160(4):1279-92.

17.

Functional differentiation of RAMP2 and RAMP3 in their regulation of the vascular system.

Yamauchi A, Sakurai T, Kamiyoshi A, Ichikawa-Shindo Y, Kawate H, Igarashi K, Toriyama Y, Tanaka M, Liu T, Xian X, Imai A, Zhai L, Owa S, Arai T, Shindo T.

J Mol Cell Cardiol. 2014 Dec;77:73-85. doi: 10.1016/j.yjmcc.2014.09.017.

PMID:
25264174
18.

Adrenomedullin expression in the developing human fetal lung.

Ramos CG, Sun X, Johnson EB, Nelson HE, Gonzalez Bosc LV.

J Investig Med. 2014 Jan;62(1):49-55. doi: 10.2310/JIM.0000000000000020.

PMID:
24169318
19.

Adrenomedullin and its receptor complexes in remnant kidneys of rats with renal mass ablation: decreased expression of calcitonin receptor-like receptor and receptor-activity modifying protein-3.

Totsune K, Takahashi K, Mackenzie HS, Arihara Z, Satoh F, Sone M, Murakami O, Ito S, Brenner BM, Mouri T.

Peptides. 2001 Nov;22(11):1933-7.

PMID:
11754984
20.

Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion.

Keleg S, Kayed H, Jiang X, Penzel R, Giese T, Büchler MW, Friess H, Kleeff J.

Int J Cancer. 2007 Jul 1;121(1):21-32.

Supplemental Content

Support Center